From Pill to Chip: Small-Cap Pharma Company to Enter the High-Growth Semiconductor Industry with High ROE and ROCE!
From Pill to Chip:  Small-Cap Pharma Company to Enter the High-Growth Semiconductor Industry with High ROE and ROCE!

From Pill to Chip: Small-Cap Pharma Company to Enter the High-Growth Semiconductor Industry with High ROE and ROCE!

An ace investor, Ashish Kacholia holds 2.13 per cent stake in in the company, aggregating to Rs 83.71 crore.

Kiran Shroff Article rating: 4.0

An ace investor, Ashish Kacholia holds 2.13 per cent stake in in the company, aggregating to Rs 83.71 crore.

Stock below Rs 1: Shares of this small-cap company zoom 62 per cent in just 5 days as it announces rights issue!
Stock below Rs 1: Shares of this small-cap company zoom 62 per cent in just 5 days as it announces rights issue!

Stock below Rs 1: Shares of this small-cap company zoom 62 per cent in just 5 days as it announces rights issue!

The main Indian indices ended the day higher on Friday, BSE Sensex was up 1.78 per cent at a level of 58,991.52.

Kiran Shroff Article rating: 4.0

The main Indian indices ended the day higher on Friday, BSE Sensex was up 1.78 per cent at a level of 58,991.52.

Low PE high ROE multibagger stock: This small-cap company has been declared as an L-1 bidder for an order worth Rs 655.099 crore!
Low PE high ROE multibagger stock: This small-cap company has been declared as an L-1 bidder for an order worth Rs 655.099 crore!

Low PE high ROE multibagger stock: This small-cap company has been declared as an L-1 bidder for an order worth Rs 655.099 crore!

The stock gave multibagger returns of 192 per cent in just 2 years with a PE of 13.71x whereas the industry PE is 33.22x and ROE of 30.51 per cent

Kiran Shroff Article rating: 4.7

The stock gave multibagger returns of 192 per cent in just 2 years with a PE of 13.71x whereas the industry PE is 33.22x and ROE of 30.51 per cent

Don’t miss action in this stock that has announced rights issue!
Don’t miss action in this stock that has announced rights issue!

Don’t miss action in this stock that has announced rights issue!

In FY22, net sales rose by 27.48 per cent over FY21. In FY22, the company reported a net profit of Rs 14 crore compared to a net loss of Rs 103 crore in FY21.  

Kiran Shroff Article rating: 4.7

In FY22, net sales rose by 27.48 per cent over FY21. In FY22, the company reported a net profit of Rs 14 crore compared to a net loss of Rs 103 crore in FY21.  

 

DSIJ MINDSHARE

Mkt Commentary14-Jun, 2024

Penny Stocks14-Jun, 2024

Penny Stocks14-Jun, 2024

Penny Stocks14-Jun, 2024

Penny Stocks14-Jun, 2024

Knowledge

MF13-Jun, 2024

General10-Jun, 2024

MF6-Jun, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR